Directed Differentiation of Patient-Specific Induced Pluripotent Stem Cells Identifies the Transcriptional Repression and Epigenetic Modification of NKX2-5, HAND1, and NOTCH1 in Hypoplastic Left Heart Syndrome

The genetic basis of hypoplastic left heart syndrome (HLHS) remains unknown, and the lack of animal models to reconstitute the cardiac maldevelopment has hampered the study of this disease. This study investigated the altered control of transcriptional and epigenetic programs that may affect the development of HLHS by using disease-specific induced pluripotent stem (iPS) cells. Cardiac progenitor cells (CPCs) were isolated from patients with congenital heart diseases to generate patient-specific iPS cells. Comparative gene expression analysis of HLHS- and biventricle (BV) heart-derived iPS cells was performed to dissect the complex genetic circuits that may promote the disease phenotype. Both HLHS- and BV heart-derived CPCs were reprogrammed to generate disease-specific iPS cells, which showed characteristic human embryonic stem cell signatures, expressed pluripotency markers, and could give rise to cardiomyocytes. However, HLHS-iPS cells exhibited lower cardiomyogenic differentiation potential than BV-iPS cells. Quantitative gene expression analysis demonstrated that HLHS-derived iPS cells showed transcriptional repression of NKX2-5, reduced levels of TBX2 and NOTCH/HEY signaling, and inhibited HAND1/2 transcripts compared with control cells. Although both HLHS-derived CPCs and iPS cells showed reduced SRE and TNNT2 transcriptional activation compared with BV-derived cells, co-transfection of NKX2-5, HAND1, and NOTCH1 into HLHS-derived cells resulted in synergistic restoration of these promoters activation. Notably, gain- and loss-of-function studies revealed that NKX2-5 had a predominant impact on NPPA transcriptional activation. Moreover, differentiated HLHS-derived iPS cells showed reduced H3K4 dimethylation as well as histone H3 acetylation but increased H3K27 trimethylation to inhibit transcriptional activation on the NKX2-5 promoter. These findings suggest that patient-specific iPS cells may provide molecular insights into complex transcriptional and epigenetic mechanisms, at least in part, through combinatorial expression of NKX2-5, HAND1, and NOTCH1 that coordinately contribute to cardiac malformations in HLHS.

[1]  E. Sernagor,et al.  An Induced Pluripotent Stem Cell Model of Hypoplastic Left Heart Syndrome (HLHS) Reveals Multiple Expression and Functional Differences in HLHS‐Derived Cardiac Myocytes , 2014, Stem cells translational medicine.

[2]  M. Govoni,et al.  Epigenetic Signature of Early Cardiac Regulatory Genes in Native Human Adipose-Derived Stem Cells , 2013, Cell Biochemistry and Biophysics.

[3]  Carlos Torroja,et al.  Mutations in the NOTCH pathway regulator MIB1 cause left ventricular noncompaction cardiomyopathy , 2013, Nature Medicine.

[4]  L. Galletti,et al.  Identification of de novo mutations and rare variants in hypoplastic left heart syndrome , 2012, Clinical genetics.

[5]  J. Epstein,et al.  Coordinating tissue interactions: Notch signaling in cardiac development and disease. , 2012, Developmental cell.

[6]  B. McCrindle,et al.  Left ventricular hypoplasia: a spectrum of disease involving the left ventricular outflow tract, aortic valve, and aorta. , 2012, Journal of the American College of Cardiology.

[7]  S. Bossmann,et al.  Interleukin-1β and transforming growth factor-β cooperate to induce neurosphere formation and increase tumorigenicity of adherent LN-229 glioma cells , 2012, Stem Cell Research & Therapy.

[8]  Franziska Greulich,et al.  Mechanisms of T-box gene function in the developing heart. , 2011, Cardiovascular research.

[9]  K. Narsinh,et al.  Derivation of Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling , 2011, Circulation research.

[10]  D. Srivastava,et al.  Hand2 function in second heart field progenitors is essential for cardiogenesis. , 2011, Developmental biology.

[11]  J. Epstein.  Franklin H. Epstein Lecture. Cardiac development and implications for heart disease. , 2010, The New England journal of medicine.

[12]  V. Band,et al.  Telomerase-immortalized human mammary stem/progenitor cells with ability to self-renew and differentiate , 2010, Proceedings of the National Academy of Sciences.

[13]  P. Collas,et al.  Promoter DNA Methylation Patterns of Differentiated Cells Are Largely Programmed at the Progenitor Stage , 2010, Molecular biology of the cell.

[14]  E. Sasaki,et al.  Nongenetic method for purifying stem cell–derived cardiomyocytes , 2010, Nature Methods.

[15]  H. Okano,et al.  ABCB1 is predominantly expressed in human fetal neural stem/progenitor cells at an early development stage , 2009, Journal of neuroscience research.

[16]  Kirk R. Kanter,et al.  The effect of age, diagnosis, and previous surgery in children and adults undergoing heart transplantation for congenital heart disease. , 2009, Journal of the American College of Cardiology.

[17]  K. Mesbah,et al.  Signaling Pathways Controlling Second Heart Field Development , 2009, Circulation research.

[18]  Lisa J. Martin,et al.  Hypoplastic left heart syndrome links to chromosomes 10q and 6q and is genetically related to bicuspid aortic valve. , 2009, Journal of the American College of Cardiology.

[19]  H. Matsubara,et al.  Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction. , 2008, Journal of the American College of Cardiology.

[20]  R. Rizzi,et al.  Notch1 regulates the fate of cardiac progenitor cells , 2008, Proceedings of the National Academy of Sciences.

[21]  J. Belmont,et al.  NOTCH1 mutations in individuals with left ventricular outflow tract malformations reduce ligand-induced signaling. , 2008, Human molecular genetics.

[22]  Paul H Lerou,et al.  Generation of human-induced pluripotent stem cells , 2008, Nature Protocols.

[23]  J. Borlak,et al.  A loss-of-function mutation in the binding domain of HAND1 predicts hypoplasia of the human hearts. , 2008, Human molecular genetics.

[24]  B. Bruneau.  The developmental genetics of congenital heart disease , 2008, Nature.

[25]  B. Thiers.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2008 .

[26]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[27]  T. Graf.  Faculty Opinions recommendation of Induction of pluripotent stem cells from adult human fibroblasts by defined factors. , 2007 .

[28]  H. Matsubara,et al.  Human cardiac stem cells exhibit mesenchymal features and are maintained through Akt/GSK-3beta signaling. , 2007, Biochemical and biophysical research communications.

[29]  A. Fischer,et al.  Developmental patterning of the cardiac atrioventricular canal by Notch and Hairy-related transcription factors , 2006, Development.

[30]  Howard Y. Chang,et al.  Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation , 2006, Proceedings of the National Academy of Sciences.

[31]  K. Igarashi,et al.  Activation of Notch1 signaling in cardiogenic mesoderm induces abnormal heart morphogenesis in mouse , 2006, Development.

[32]  David J. Miller,et al.  Gene Regulatory Networks in the Evolution and Development of the Heart , 2006 .

[33]  D. Srivastava,et al.  Mutations in NOTCH1 cause aortic valve disease , 2005, Nature.

[34]  D. Srivastava,et al.  The Hand1 and Hand2 transcription factors regulate expansion of the embryonic cardiac ventricles in a gene dosage-dependent manner , 2004, Development.

[35]  E. Goldmuntz,et al.  NKX2.5 mutations in patients with congenital heart disease. , 2004, Journal of the American College of Cardiology.

[36]  E. Goldmuntz,et al.  NKX2.5mutations in patients with congenital heart disease , 2003 .

[37]  Michael D. Schneider,et al.  Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[38]  D. Torella,et al.  Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration , 2003, Cell.

[39]  P. Krieg,et al.  Transgenic analysis of the atrialnatriuretic factor (ANF) promoter: Nkx2-5 and GATA-4 binding sites are required for atrial specific expression of ANF. , 2003, Developmental biology.

[40]  T. Asai,et al.  Right ventricle-pulmonary artery shunt in first-stage palliation of hypoplastic left heart syndrome. , 2003, The Journal of thoracic and cardiovascular surgery.

[41]  D. Elliott,et al.  Cardiac homeobox gene NKX2-5 mutations and congenital heart disease: associations with atrial septal defect and hypoplastic left heart syndrome. , 2003, Journal of the American College of Cardiology.

[42]  D. Srivastava,et al.  The combinatorial activities of Nkx2.5 and dHAND are essential for cardiac ventricle formation. , 2001, Developmental biology.

[43]  R. Schwartz,et al.  GATA-4 and Nkx-2.5 Coactivate Nkx-2 DNA Binding Targets: Role for Regulating Early Cardiac Gene Expression , 1998, Molecular and Cellular Biology.

[44]  J. Cross,et al.  The Hand1 bHLH transcription factor is essential for placentation and cardiac morphogenesis , 1998, Nature Genetics.

[45]  D. Srivastava,et al.  Regulation of cardiac mesodermal and neural crest development by the bHLH transcription factor, dHAND , 1997, Nature Genetics.

[46]  E. Bove,et al.  Hypoplastic left heart syndrome , 1997, BMJ.